Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Urticaria Clinical Trials
Urticaria clinical trials are recruiting across 50 cities. Here are the cities with the most active studies:
Urticaria Trial Phases
13 research organizations are sponsoring urticaria trials.
About Urticaria
Urticaria (hives) presents as raised, itchy welts on the skin triggered by allergens, medications, infections, or other factors. Acute urticaria resolves within six weeks, while chronic forms persist longer. Treatment includes antihistamines, corticosteroids for severe episodes, and biologics for chronic cases.
Clinical trials are advancing new treatments for urticaria. Currently, 19 studies are recruiting a combined 6,500 participants across the United States. Research is being conducted by 13 organizations including Novartis Pharmaceuticals, Foundation For Rare Disease Research, Celldex Therapeutics and 10 others.
2026 Urticaria Research Landscape
As of September 2026, the urticaria clinical trial landscape includes 19 actively recruiting studies across 50 cities in the United States. These studies are collectively seeking 6,500 participants, with an average enrollment target of 342 per study.
The research spans multiple phases of development: 8 studies are in PHASE3, 4 studies are in PHASE2, 2 studies are in PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some urticaria treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 13 different organizations, including Novartis Pharmaceuticals, Foundation For Rare Disease Research, Celldex Therapeutics, CSL Behring, Pfizer, and 8 others. The large number of sponsors reflects significant research interest and investment in urticaria treatment advancement.
Geographically, urticaria trials are most concentrated in St Louis, Missouri (6 trials); Wheaton, Maryland (5 trials); Little Rock, Arkansas (5 trials); San Diego, California (4 trials); Walnut Creek, California (4 trials) and 7 other cities.
Featured Urticaria Studies
Highlighted recruiting studies for urticaria, selected by enrollment size and research scope.
Remibrutinib in Real-world Clinical Practice
Prospective, multi-country, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical p...
Angioedema Biomarker Research Study
This clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial angioedema. The primary objective is to assess the efficiency of novel diagnostic assays, both individually and in combi...
Remibrutinib in Real-world Clinical Practice - a US Sub-study
Prospective, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical practice populat...
Frequently Asked Questions About Urticaria Clinical Trials
Are there urticaria clinical trials near me?
Yes, there are 19 urticaria clinical trials currently recruiting across 50+ cities in the United States, including St Louis, Missouri; Wheaton, Maryland; Little Rock, Arkansas. Browse the studies above to find one at a location convenient for you.
How do I join a urticaria clinical trial?
To join a urticaria clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are urticaria clinical trials free?
Yes, participation in urticaria clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of urticaria treatments are being studied?
Current urticaria clinical trials are testing a range of approaches across PHASE3 (8 studies), PHASE2 (4 studies), PHASE1 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 13 research organizations.
Is it safe to participate in urticaria clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated September 2, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated September 2, 2026 · Data from ClinicalTrials.gov